niceritrol has been researched along with Hyperlipoproteinemia Type III in 1 studies
Niceritrol: An ester of nicotinic acid that lowers cholesterol and triglycerides in total plasma and in the VLD- and LD-lipoprotein fractions.
Hyperlipoproteinemia Type III: An autosomal recessively inherited disorder characterized by the accumulation of intermediate-density lipoprotein (IDL or broad-beta-lipoprotein). IDL has a CHOLESTEROL to TRIGLYCERIDES ratio greater than that of VERY-LOW-DENSITY LIPOPROTEINS. This disorder is due to mutation of APOLIPOPROTEINS E, a receptor-binding component of VLDL and CHYLOMICRONS, resulting in their reduced clearance and high plasma levels of both cholesterol and triglycerides.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kibata, M | 1 |
Ishida, M | 1 |
Asano, K | 1 |
Uehara, H | 1 |
Saito, K | 1 |
Fuchimoto, T | 1 |
Ugaki, K | 1 |
Murakami, H | 1 |
Matoba, K | 1 |
Kotakemori, Y | 1 |
Shirai, K | 1 |
Yoshioka, H | 1 |
Nanba, M | 1 |
Yasuda, M | 1 |
Ishizaki, M | 1 |
Kitagawa, N | 1 |
Ikejiri, K | 1 |
Inohara, R | 1 |
Lee, BJ | 1 |
Saino, S | 1 |
Sakado, J | 1 |
Matuzaka, H | 1 |
Numata, K | 1 |
Mandai, M | 1 |
Miyake, K | 1 |
Nakamura, K | 1 |
1 other study available for niceritrol and Hyperlipoproteinemia Type III
Article | Year |
---|---|
Clinical study of niceritrol on serum lipids in the treatment of hyperlipidemia.
Topics: Cholesterol; Female; Humans; Hyperlipoproteinemia Type II; Hyperlipoproteinemia Type III; Hypolipide | 1980 |